GlassScriptPhysician profile
Karan Madan
NPI 1568410397
$8,287.39
in general payments reported to CMS, 2019-2025
51 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,904 · 2020: $1,193 · 2021: $911 · 2022: $1,312 · 2023: $736 · 2024: $1,003 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,967.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,450.51 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,102.07 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, General - Pain Management |
| Collegium Pharmaceutical, INC. | $1,042.58 | 2019-2025 | Belbuca, Xtampza |
| Horizon Therapeutics Plc | $768.43 | 2019-2022 | |
| Nevro Corp. | $675.99 | 2019-2024 | Senza |
| Medtronic, INC. | $342.73 | 2021-2025 | Intellis Adaptivestim, Venaseal |
| Saluda Medical Americas, INC. | $313.46 | 2023-2025 | Evoke, Evoke Scs |
| Arbor Pharmaceuticals, INC. | $243.27 | 2019-2022 | |
| Si-Bone, INC. | $191.52 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $178.21 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $171.30 | 2019-2021 | |
| Medtronic USA, INC. | $161.66 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.03 | 2019-2022 | |
| Biogen, INC. | $130.25 | 2019-2025 | Spinraza |
| Abbvie INC. | $126.55 | 2022-2023 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Madan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.